|
Market Closed -
Nasdaq
08:00:00 21/11/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 0.1459 USD | +2.24% |
|
-9.15% | -85.41% |
| Market Cap | 9.89M 9.01M 8.3M 7.55M 14.16M 916M 14.88M 101M 40.15M 500M 37.1M 36.32M 1.57B | P/E 2026 * |
-0.17x | P/E 2027 * | -0.26x |
|---|---|---|---|---|---|
| Enterprise Value | 9.89M 9.01M 8.3M 7.55M 14.16M 916M 14.88M 101M 40.15M 500M 37.1M 36.32M 1.57B | EV / Sales 2026 * |
3.78x | EV / Sales 2027 * | 7.91x |
| Free-Float |
93.51% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TCRX | Delayed | |
| TCRX | Real-time |
Last Transcript: TScan Therapeutics, Inc.
| 1 day | +2.24% | ||
| 1 week | -9.15% | ||
| Current month | -16.39% | ||
| 1 month | -34.87% | ||
| 3 months | -81.28% | ||
| 6 months | -85.70% | ||
| Current year | -85.41% |
| 1 week | 0.14 | 0.17 | |
| 1 month | 0.14 | 0.23 | |
| Current year | 0.14 | 1.47 | |
| 1 year | 0.14 | 1.47 | |
| 3 years | 0.14 | 9.69 | |
| 5 years | 0.14 | 9.69 | |
| 10 years | 0.14 | 14.71 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gavin MacBeath
CEO | Chief Executive Officer | 56 | 28/03/2023 |
Dawn Pinchasik
CTO | Chief Tech/Sci/R&D Officer | - | 06/02/2024 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Katina Dorton
BRD | Director/Board Member | 68 | 23/03/2021 |
Gavin MacBeath
BRD | Director/Board Member | 56 | 24/05/2023 |
Stephen Biggar
CHM | Chairman | 55 | 12/06/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/10/26 | Free | Chief Executive Officer | 1,000,000 | 1.5747% | ||
| 1/10/26 | Free | General Counsel | 300,000 | 0.4724% | ||
| 20/5/26 | Free | Director | 67,000 | 0.1200% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.24% | -9.15% | -84.85% | -96.51% | 9.89M | ||
| -2.49% | -3.76% | +53.38% | +62.10% | 63.66B | ||
| -0.63% | -2.91% | +6.55% | +89.34% | 58.56B | ||
| -2.37% | -2.22% | +21.77% | +84.58% | 54.19B | ||
| -2.19% | -6.15% | +12.43% | +111.40% | 44.66B | ||
| -1.89% | -7.28% | +9.30% | +18.50% | 40.51B | ||
| -0.93% | -0.47% | +19.34% | +41.83% | 36.27B | ||
| +1.11% | -6.44% | +127.46% | +675.37% | 34.89B | ||
| -0.80% | +0.61% | +76.27% | +61.80% | 32.26B | ||
| -2.17% | +16.65% | -28.89% | +479.93% | 31.01B | ||
| Average | -1.01% | -2.01% | +21.28% | +152.83% | 40B | |
| Weighted average by Cap. | -1.48% | -1.85% | +31.83% | +155.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.62M 2.39M 2.2M 2M 3.75M 243M 3.94M 26.75M 10.63M 132M 9.83M 9.62M 416M | 1.25M 1.14M 1.05M 954K 1.79M 116M 1.88M 12.77M 5.07M 63.22M 4.69M 4.59M 198M |
| Net income | -113M -103M -95.02M -86.43M -162M -10.48B -170M -1.16B -460M -5.73B -425M -416M -17.97B | -73.48M -66.92M -61.67M -56.09M -105M -6.8B -111M -751M -298M -3.72B -276M -270M -11.66B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/11/26 | USD 0.1459 | +2.24% | 391,759 |
| 19/11/26 | USD 0.1427 | -3.84% | 507,198 |
| 18/11/26 | USD 0.1484 | -1.72% | 656,745 |
| 17/11/26 | USD 0.1510 | +4.07% | 310,648 |
| 16/11/26 | USD 0.1451 | -9.65% | 404,948 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- TCRX Stock
Select your edition
All financial news and data tailored to specific country editions
















